REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 4 Sponsors

Mar 30, 2026 · Senate

The committee on HHS deferred the measure.

Mar 27, 2026 · Senate

The committee(s) on HHS has scheduled a public hearing on 03-30-26 1:07PM; Conference Room 225 & Videoconference.

Feb 13, 2026 · Senate

Referred to HHS, WAM.

Feb 6, 2026 · Senate

Offered.

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 4%, measured from HI's completed sessions
Momentum -4 30/100 from the pace of recorded action
Time since last action -22 248 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.